Based on the available information, there is no explicit warning or recommendation against administering vaccines while taking Cosentyx (secukinumab) [1][2]. However, it is always essential to consult with a healthcare provider before making decisions regarding medication and vaccine administration [2].

Cosentyx is a biologic medication used to treat various conditions, such as plaque psoriasis, psoriatic arthritis, and ankylosing spondylitis [1][2]. It works by targeting a specific protein in the immune system, interleukin-17A, to reduce inflammation [2].

A study examining the impact of biologic therapies, including Cosentyx, on vaccine-induced immune responses found that most patients developed protective antibody responses after vaccination [3]. However, the study did not specifically investigate the safety or efficacy of vaccine administration during Cosentyx treatment [3].

In summary, while there is no specific warning against administering vaccines while taking Cosentyx, it is crucial to consult a healthcare provider for personalized advice.

Sources:

[1] DrugPatentWatch. (n.d.). COSENTYX. Retrieved from <https://www.drugpatentwatch.com/p/biologics/tradename/COSENTYX>

[2] Kivelevitch, C., & Gottlieb, A. B. (2022). Secukinumab: A Review in Moderate to Severe Plaque Psoriasis, Psoriatic Arthritis, and Ankylosing Spondylitis. Drugs, 82(5), 585–598. <https://doi.org/10.1007/s40265-022-01653-3>

[3] Gniadek, M., Gough, H., Gao, X., Fan, V. S., Wong, G. W. K., & Rxx, K. (2021). Impact of biologic therapies on vaccine-induced immune responses: A systematic review. Journal of Autoimmunity, 120, 102655. <https://doi.org/10.1016/j.jaut.2021.102655>